M.F. Egan

468 total citations
7 papers, 310 citations indexed

About

M.F. Egan is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, M.F. Egan has authored 7 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 3 papers in Psychiatry and Mental health and 2 papers in Molecular Biology. Recurrent topics in M.F. Egan's work include Schizophrenia research and treatment (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). M.F. Egan is often cited by papers focused on Schizophrenia research and treatment (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). M.F. Egan collaborates with scholars based in United States, United Kingdom and Japan. M.F. Egan's co-authors include Farouk Karoum, Gregory W. Albers, Thomas M. Hyde, A Reeve, Ahmed Elkashef, Arnon Blum, Richard Jed Wyatt, Richard A. Wiklund, Scott Gazelle and J.‐P. Stahl and has published in prestigious journals such as American Journal of Psychiatry, Gut and British Journal of Pharmacology.

In The Last Decade

M.F. Egan

7 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.F. Egan United States	6	97	73	66	58	54	7	310
Nien-Chen Li United States	7	25 0.3×	70 1.0×	79 1.2×	20 0.3×	140 2.6×	7	438
Luca Paulon Italy	9	23 0.2×	32 0.4×	24 0.4×	18 0.3×	5 0.1×	21	314
Yasuhiko Hashimoto Japan	12	165 1.7×	16 0.2×	68 1.0×	3 0.1×	67 1.2×	33	473
Alicia R Desilets United States	11	26 0.3×	29 0.4×	36 0.5×	7 0.1×	60 1.1×	19	451
Berna Terzi̇oğlu Bebi̇toğlu Türkiye	10	29 0.3×	13 0.2×	71 1.1×	12 0.2×	31 0.6×	35	299
Jordan Sim Singapore	11	55 0.6×	9 0.1×	16 0.2×	24 0.4×	23 0.4×	18	453
LeAnne Skordos United States	5	49 0.5×	15 0.2×	10 0.2×	21 0.4×	20 0.4×	8	238
Michelle V. Middle Germany	6	115 1.2×	88 1.2×	25 0.4×	2 0.0×	45 0.8×	8	482
Sedef Gidener Türkiye	13	124 1.3×	13 0.2×	25 0.4×	3 0.1×	44 0.8×	50	420
Richard Bergstrom United States	10	159 1.6×	20 0.3×	27 0.4×	2 0.0×	43 0.8×	16	460

Countries citing papers authored by M.F. Egan

Since Specialization

Citations

This map shows the geographic impact of M.F. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. Egan more than expected).

Fields of papers citing papers by M.F. Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. Egan. The network helps show where M.F. Egan may publish in the future.

Co-authorship network of co-authors of M.F. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. Egan. A scholar is included among the top collaborators of M.F. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. Egan. M.F. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Shapiro, Daniel I., et al.. (2009). The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings. Schizophrenia Research. 112(1-3). 136–142. 31 indexed citations

2.

Stahl, J.‐P., Warren S. Sandberg, Bethany Daily, et al.. (2006). Reorganizing patient care and workflow in the operating room: a cost-effectiveness study. Surgery. 139(6). 717–728. 96 indexed citations

3.

Chrapusta, Stanisław J. & M.F. Egan. (2005). Poor evidence for depolarization block but uncoupling of nigral from striatal dopamine metabolism after chronic haloperidol treatment in the rat. Journal of Neural Transmission. 113(5). 573–582. 2 indexed citations

4.

Karoum, Farouk & M.F. Egan. (1992). Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol. British Journal of Pharmacology. 105(3). 703–707. 43 indexed citations

5.

Egan, M.F., Thomas M. Hyde, Gregory W. Albers, et al.. (1992). Treatment of tardive dyskinesia with vitamin E. American Journal of Psychiatry. 149(6). 773–777. 120 indexed citations

6.

Watanapa, P, M.F. Egan, Pierre H. Deprez, et al.. (1992). Role of cholecystokinin in pancreatic adaptation to massive enterectomy.. Gut. 33(7). 959–964. 8 indexed citations

7.

El‐Mallakh, Rif S., M.F. Egan, & Robert Wyatt. (1992). Creatine Kinase and Enolase: Intracellular Enzymes Serving as Markers of Central Nervous System Damage in Neuropsychiatric Disorders. Psychiatry. 55(4). 392–402. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact